Skip to main content
. 2024 Jun 5;28(2):360. doi: 10.3892/ol.2024.14493

Table III.

Serum CEA and CA19-9 in cell-derived xenograft model mice.

Group CEA, ng/ml (average) CA19-9, U/ml (average)
Control (n=3) <0.5 <2.0
Tumor bearing (n=5) 17.0 15,000.0
No recurrence (n=3) <0.5 <2.0
With recurrence (n=2) 17.8 1173.7

CEA, Carcinoembryonic antigen; CA19-9, carbohydrate antigen 19-9.